Evening Symposium
Chairs: A. Wells London (United Kingdom)
Aims: Organised by Boehringer Ingelheim International GmbH

Welcome and introduction A. Wells (London, United Kingdom)
The pathogenesis of IPF: what is the latest paradigm? P. Sime (Rochester, United States of America)
Splitting: the road to precision medicine in IPF? E. White (Ann Arbor, United States of America)
Lumping: are the commonalities among fibrosing ILDs more important than the differences? V. Cottin (Lyon, France)
How should we approach the treatment of progressive fibrosing ILDs? K. Brown (Denver, United States of America)
SSc-ILD: are we entering a new chapter in treatment? T. Maher (St. Albans, United Kingdom)